Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients.

1999;14:2813–5. 3. Vanholder R, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E, et al. Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 1995;47:510–7. 4. Dou L, Cerini C, Brunet P, Guilianelli C, Moal V, Grau G, et al. p-Cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int 2002;62:1999–2009. 5. Dou L, Bertrand E, Cerini C, Faure V, Sampol J, Vanholder R, et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004;65:442–51. 6. Cerini C, Dou L, Anfosso F, Sabatier F, Moal V, Glorieux G, et al. p-Cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 2004;92:140–50. 7. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms. Kidney Int 2003;64:2238–43. 8. De Smet R, Van Kaer J, Van Vlem B, De Cubber A, Brunet P, Lameire N, et al. Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 2003;49:470–8. 9. Pierce CH, Chen Y, Dills RL, Kalman DA, Morgan MS. Toluene metabolites as biological indicators of exposure. Toxicol Lett 2002;129:65–76. 10. Bone E, Tamm A, Hill M. The production of urinary phenols by the gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr 1976;29:1448–54. 11. Ogata N, Matsushima N, Shibata T. Pharmacokinetics of wood creosote: glucuronic acid and sulfate conjugation of phenolic compounds. Pharmacology 1995;51:195–204. 12. Powell GM, Miller JJ, Olavesen AH, Curtis CG. Liver as major organ of phenol detoxication? Nature 1974;252:234–5. 13. Lauterbach F, Czekay RP, Sund RB. Compartmentation of intestinal drug sulphoconjugation. Incorporation of luminal and contraluminal [S]sulphate into 1-naphthol by the isolated mucosa of guinea pig jejunum and colon. Biochem Pharmacol 1993;46:1339–47. 14. Wengle B, Hellström K. Volatile phenols in serum of uraemic patients. Clin Sci 1972;43:493–8. 15. Niwa T, Maeda K, Ohki T, Saito A, Kobayashi K. A gas chromatographic-mass spectrometric analysis for phenols in uremic serum. Clin Chim Act 1981; 110:51–7. 16. Lesaffer G, De Smet R, Belpaire FM, Van Vlem B, Van Hulle M, Cornelis R, et al. Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization. Nephrol Dial Transplant 2003;18: 1299–306. 17. Niwa T. Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection. Clin Chem 1993;39:108–11. 18. De Smet R, David F, Sandra P, Van Kaer J, Lesaffer G, Dhondt A, et al. A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure. Clin Chim Acta 1998;278:1–21. 19. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study. Am J Kidney Dis 2004;44:278–85. 20. Mabuchi H, Nakahashi H. Profiling of endogenous ligand solutes that bind to serum proteins in sera of patients with uremia. Nephron 1986;43:110–6. 21. Wardle EN, Wilkinson K. Free phenols in chronic renal failure. Clin Nephrol 1976;6:361–4. 22. Armbruster DA, Tillman MD, Hubbs LM. Limit of detection (LOD)/limit of quantification: comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. Clin Chem 1994;40: 1233–8. 23. Morinaga Y, Fuke C, Arao T, Miyazaki T. Quantitative analysis of cresol and its metabolites in biological materials and distribution in rats after oral administration. Leg Med 2004;6:32–40.